[Regional chemotherapy of malignant melanoblastomas of the extremities].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects; D002648:Child; D005121:Extremities; D005260:Female; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007970:Leukopenia; D008197:Lymph Node Excision; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008558:Melphalan / Q000008:administration & dosage*; D008722:Methods; D008875:Middle Aged; D011183:Postoperative Complications; D012509:Sarcoma / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy*
D008558:Melphalan
O regionarnoĭ khimioterapii zlokachestvennykh melanoblastom konechnosteĭ.